Myotonic disorders: A review article
Open Access
- 5 January 2016
- journal article
- review article
- Vol. 15 (1) , 46-53
Abstract
The myotonic disorders are a heterogeneous group of genetically determined diseases that are unified by the presence of myotonia, which is defined as failure of muscle relaxation after activation. The presentation of these disorders can range from asymptomatic electrical myotonia, as seen in some forms of myotonia congenita (MC), to severe disability with muscle weakness, cardiac conduction defects, and other systemic features as in myotonic dystrophy type I (DM1). In this review, we describe the clinical features and pathophysiology of the different myotonic disorders, their laboratory and electrophysiologic findings and briefly review the currently available treatments.Keywords
This publication has 100 references indexed in Scilit:
- Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotoniasNeuromuscular Disorders, 2013
- Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategyEuropean Journal of Clinical Pharmacology, 2012
- Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic MyotoniaJAMA, 2012
- Increased Cancer Risks in Myotonic DystrophyMayo Clinic Proceedings, 2012
- Cancer Risk Among Patients With Myotonic Muscular DystrophyJAMA, 2011
- Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in FinlandEuropean Journal of Human Genetics, 2011
- Refined exercise testing can aid dna‐based diagnosis in muscle channelopathiesAnnals of Neurology, 2011
- The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatmentBrain, 2009
- Myotonic dystrophy type 2 found in two of sixty‐three persons diagnosed as having fibromyalgiaArthritis & Rheumatism, 2008
- Does modafinil enhance activity of patients with myotonic dystrophy?Journal of Neurology, 2007